BioInformant Worldwide, L.L.C. Market Research Reports

Executive Summary Mesenchymal stem cells (MSCs) are multipotent cells that can differentiate into a variety of cell types, including osteoblasts, chondrocytes, myocytes, adipocytes, and potentially other cell types. ...

Executive Summary Although long overlooked, exosomes are rapidly gaining momentum as a novel strategy for accessing the therapeutic effects of stem cells without the risks and difficulties of administering the cells to pat...

Executive Summary Over the past five years, the global cord blood banking industry has substantially matured and consolidated. This has created both serious threats and novel opportunities for the industry. Serious threats...

Executive Summary Traditionally, one of the major issues with commercializing cell therapy products has been manufacturing bottlenecks. The heterogeneous nature of cell therapy products has introduced manufacturing complex...

Executive Summary Stem cell research has been in process for over five decades. Stem cells have a unique ability to divide and replicate repeatedly, as well as an “unspecialized” nature that allows them to diff...

Claim this global strategic report to understand unique product opportunities by stem cell type, derive more revenue from products sold to stem cell scientists, and identify new product development opportunities before the competition. Use the &ld...

Executive SummaryThe global cord blood banking industry has matured substantially over the past few years, creating both serious threats and novel opportunities. Serious threats to the industry include:New accre...

Overview SummaryRecent months have seen  the first iPSC clinical trial in humans, creation of the world’s largest iPSC biobank, major funding awards, a historic challenge to the “Yamanaka Patent”, a S...